We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Roche Recognizes med fusion as a Molecular Center of Excellence

By LabMedica International staff writers
Posted on 06 Jun 2012
Roche Diagnostics (Roche; Basel, Switzerland), a biotech company focused on research-based healthcare, has formed an alliance with med fusion LLC (Lewisville, Texas, USA), an integrated laboratory and clinical trials service organization, designating the company as a Roche Molecular Center of Excellence (MCOE) for the next five years.

Established in 2002, Roche's MCOE program allows noncompeting regional laboratories across the United States to collaborate and capitalize on molecular testing instruments in order to advance test methodologies and technology.

As a nationally recognized Roche MCOE, med fusion's molecular diagnostics laboratory will offer healthcare professionals and patients some of the latest and most advanced molecular technologies, including Roche's cobas 4800 BRAF V600 Mutation Test, a companion diagnostic that identifies patients who are eligible for treatment with the ZELBORAF (vemurafenib) drug for inoperable or metastatic melanoma, a deadly form of skin cancer. More...


"Roche is very pleased to welcome med fusion into the Molecular Center of Excellence alliance," said Whitney Green, senior vice president, molecular diagnostics, Roche Diagnostics Corporation. "We value their expertise and look forward to working together in implementing molecular technologies in the advancement of personalized medicine."

med fusion is one of 35 labs in the United States and 3 in Texas that have received this accolade. According to Dr. Thomas Lohmann, chief medical officer, med fusion, the partnership with Roche will help the company provide healthcare professionals and patients with improved diagnostic services.

"This relationship with Roche will help keep med fusion on the leading edge of technology and help ensure that we are supporting physicians and patients with the most advanced molecular technologies," added Dr. Lohmann.

Roche is an industry leader in pharmaceuticals and diagnostics, providing a broad range of products and services for the early detection, prevention, diagnosis, and treatment of diseases.



Related Links:

Roche Diagnostics

med fusion


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.